QURE

uniQure N.V.

Price

$44.51

return (12m)

170.00%

p/e

-11.67

p/bv

9.08

DIVIDEND YIELD

0.00%

QURE price

uniQure

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment QURE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.55%

3 months

59.71%

1 year

170.00%

2 years

686.40%

5 years

22.35%

10 years

466.28%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals QURE

Valuation

P/E

-11.67

Sector -3.82

Industry -3.82

P/BV

9.08

Sector 2.08

Industry 2.08

P/Revenue (PSR)

157.63

Sector 2.04

Industry 2.04

EV/EBITDA

-36.42

Sector -226.01

Industry -226.01

EV/EBIT

-33.66

Sector -49.26

Industry -49.26

P/EBITDA

-17.21

Sector -21.23

Industry -21.23

P/EBIT

-15.87

Sector -31.44

Industry -31.44

P/Total Assets

2.99

Sector 1.22

Industry 1.22

P/Net Current Assets

16.99

Sector -10.53

Industry -10.53

P/Working Capital

3.92

Sector -172.76

Industry -172.76

EPS

-3.81

Sector -1.85

Industry -1.85

BVPS

4.89

Sector 2.00

Industry 2.00

Efficiency

Gross Margin

92.49%

Sector 40.67%

Industry 40.67%

EBITDA Margin

-1,026.28%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-1,110.29%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

-100.00%

Sector -35.88%

Industry -35.88%

Net Profit Margins

-100.00%

Sector -36.71%

Industry -36.71%

Asset Turnover

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

-77.83%

Sector -58.37%

Industry -58.37%

ROA

-25.60%

Sector -61.30%

Industry -61.30%

ROIC

-89.62%

Sector -2,355.96%

Industry -2,355.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.01

Sector 2.88

Industry 2.88

Net Debt / EBITDA

12.68

Sector -14,081,727.47

Industry -14,081,727.47

Net Debt / EBIT

11.72

Sector -8.03

Industry -8.03

Net Debt / Equity

-2.35

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.15

Sector -0.85

Industry -0.85

Equity/Assets

0.33

Sector 0.45

Industry 0.45

Liabilities/Assets

0.67

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-48.67%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals QURE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
QURE uniQure N.V.	$44.51	170.00%	0.00%	-11.67	9.08	-77.83%	-100.00%
JNJ Johnson & Johnson	$265.58	52.53%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.72	24.31%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$257.12	21.52%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.07	-17.59%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$143.93	80.59%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$160.17	2.40%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.64	44.28%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.97	-49.82%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$377.35	40.29%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$781.49	40.10%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$107.20	39.40%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$881.51	24.54%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$515.44	30.65%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$234.57	56.04%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$984.39	30.14%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$41.52	28.19%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

QURE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT uniQure

uniQure N.V.

Average Investor10 user rating

4.0 (0 people)

United States

14 years

Founded: 2012

2007

Time since IPO - 19 years

332

Employees

uniQure N.V. (United States) is listed on the Nasdaq and has a market capitalization of $2.94 billion, with shareholders equity totaling $324.05 million.

The company employs approximately 332 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, uniQure N.V. reported $18.67 million in revenue, generating net income of $-252.21 million.

Key financial metrics include a P/E ratio of -11.67, a price-to-book (P/B) ratio of 9.08, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker QURE.

Market cap

$2.94 billion

Net worth

$324.05 million

$324,050,000.00

Assets

$985.10 million

$985,103,000.00

Total Shares Outstanding

66.24 million

66,243,000

Average Daily Trading Volume

$1.33 million

$1,329,113.40

Sector

Health Care

Industry

Biotechnology

QURE

QURE revenue and profits

Financial Results QURE

DRAG THE FRAME TO SEE MORE DATA

QURE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$881.51 24,54% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$234.57 56,04% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$265.58 52,53% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$257.12 21,52% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$143.93 80,59% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$160.17 4,38% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.72 24,31% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$881.51 24,54% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$234.57 56,04% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$265.58 52,53% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$257.12 21,52% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$143.93 80,59% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$160.17 4,38% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.72 24,31% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of uniQure (QURE) today?

A cotação de uniQure (QURE) hoje está em US$ 44.51, com uma variação de 170% em relação ao último ano. A cotação de uniQure (QURE) iniciou o ano negociando na casa dos US$ 23.93 e hoje está em US$ 44.51. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de uniQure (QURE) e dados de ações do Ibovespa e mercados internacionais.

Quando uniQure (QURE) paga dividendos?

uniQure (QURE) não distribuiu dividendos no último ano.

Is uniQure (QURE) a good investment?

Atualmente, uniQure (QURE) está cotada a US$ 44.51, com um P/L de -11.67, representando um desvio de -643% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 170 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 170.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy uniQure (QURE) stock?

Investir em ações de uniQure (QURE) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of uniQure (QURE) yield today?

A rentabilidade de uniQure (QURE) foi de -5.55% no último mês, 170.00% no último ano e 22.35% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de uniQure (QURE) hoje, o investimento total seria de US$ 4,451.00, com base na cotação atual de US$ 44.51.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 12,017.70
Em 5 anos: US$ 5,445.80
Em 10 anos: US$ 25,205.12

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

QURE

uniQure N.V.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment QURE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING QURE WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT uniQure

uniQure N.V.

United States

14 years

2007

332

PROFIT X PRICE QURE

Financial Results QURE

QURE cash flow

Asset, Revenue and Profit Growth - QURE

QURE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions